Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial

Packer, M; Anker, SD; Butler, J; Filippatos, G; Ferreira, JP; Pocock, SJ; Brunner-La Rocca, HP; Janssens, S; Tsutsui, H; Zhang, J; Brueckmann, M; Jamal, W; Cotton, D; Iwata, T; Schnee, J; Zannad, F

Packer, M (corresponding author), Baylor Univ, Med Ctr, Baylor Heart & Vasc Inst, 621 N Hall St, Dallas, TX 75226 USA.; Packer, M (corresponding author), Imperial Coll, London, England.

EUROPEAN HEART JOURNAL, 2021; 42 (6): 671

Abstract

Aims We evaluated the influence of sacubitril/valsartan on the effects of sodium-glucose cotransporter 2 (SGLT2) inhibition with empagliflozin in pati......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索